about
Radiation and endostatin gene therapy in a lung carcinoma model: pilot data on cells and cytokines that affect angiogenesis and immune status.Targeted gene delivery to human airway epithelial cells with synthetic vectors incorporating novel targeting peptides selected by phage display.Suppression of lung cancer progression by biocompatible glycerol triacrylate-spermine-mediated delivery of shAkt1.Modeling Pulmonary Disease Pathways Using Recombinant Adeno-Associated Virus 6.2.Ferret and pig models of cystic fibrosis: prospects and promise for gene therapy.Gene therapy for cystic fibrosis: an example for lung gene therapy.Lentivirus-mediated gene transfer to the respiratory epithelium: a promising approach to gene therapy of cystic fibrosis.Airway gene therapy and cystic fibrosis.Development of Biodegradable Polycation-Based Inhalable Dry Gene Powders by Spray Freeze DryingModulation of Treg function improves adenovirus vector-mediated gene expression in the airway.Intratympanic Gene Delivery of Antimicrobial Molecules in Otitis Media.Limitations of the murine nose in the development of nonviral airway gene transfer.Lentiviral vectors and cystic fibrosis gene therapyGene Therapy for Alpha-1 Antitrypsin Deficiency Lung Disease.Toll-like receptor 2 promiscuity is responsible for the immunostimulatory activity of nucleic acid nanocarriers.Skeletal muscle targeting in vivo electroporation-mediated HGF gene therapy of bleomycin-induced pulmonary fibrosis in mice.Effect of tolerance induction to immunodominant T-cell epitopes of Sendai virus on gene expression following repeat administration to lung.Readministration of helper-dependent adenoviral vectors to mouse airway mediated via transient immunosuppression.
P2860
Q31034778-3DF4B4ED-67B9-4311-A3AA-A5B9DE3902EDQ33208315-CF2DC456-13B2-4E51-9E09-370097FA9A7CQ34278743-CB455F6B-7E6F-4638-B5BE-2A2B8FB70323Q34470424-F0DAAC81-B80E-4140-9448-E2459292C82BQ35200182-65875FF9-916C-4977-8CD5-966E35E3F743Q35904424-5E8FB606-3D61-44FA-8392-D507BC801890Q35904439-DDB1690B-408E-48B6-923D-2B8EBA4D0423Q36079832-06AD1C9C-D4ED-44C9-A50E-56FF4079A396Q36105834-C6895B41-ADB6-4865-866F-0E5E91744766Q37624300-FFD2EA19-D4E1-46AD-A4F9-96210F35F9B3Q38424720-5B22CBC5-5A9C-4460-A409-3AFD90598DF5Q38449399-212A6F19-6136-46F4-A522-D9F29CBB2F84Q38614351-6392C1D9-501E-44F2-AEC6-4A6193E98802Q38937862-8EBC5A42-9435-45D8-A951-9972994E05C0Q41762712-EFBCBCF8-FE59-49A7-A1DC-7EE37B98F12EQ44936723-5B1668DF-79D0-49ED-B48C-8D27DE9DE01AQ45422036-35FD45F3-66FC-417B-B114-F75CEC71968BQ45863903-5561358F-08AE-4804-A7B1-863F0BACFA79
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Immunological hurdles to lung gene therapy.
@ast
Immunological hurdles to lung gene therapy.
@en
type
label
Immunological hurdles to lung gene therapy.
@ast
Immunological hurdles to lung gene therapy.
@en
prefLabel
Immunological hurdles to lung gene therapy.
@ast
Immunological hurdles to lung gene therapy.
@en
P2093
P2860
P1476
Immunological hurdles to lung gene therapy
@en
P2093
D M Geddes
U Griesenbach
P2860
P356
10.1046/J.1365-2249.2003.02124.X
P577
2003-04-01T00:00:00Z